HIV感染及高效抗逆转录病毒治疗对心血管疾病的影响
[13]Wilson PW,D'Agostino RB, Levy D, et al. Prediction of coronary heart disea se using risk factor categories[J]. Circulation,1998,97:1837-1847.
[14]Egger M, Junghans C, Friis_Moller N, et al. Highly active antiretrovira l therapy and coronary heart disease:the need for perspective[J]. AIDS,2001,15 (suppl 5):S193-S201.
[15]Hsue PY, Lo JC, Franklin A, et al. Progression of atherosclerosis as asses sed by carotid intima_media thickness in patients with HIV infection[J]. Circ ulation,2004,109:1603-1608.
[16]Stein JH, Klein MA, Bellehumeur JL, et al.Use of human immunodeficiency vi rus_1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction[J].Circulation,2001,104:257-262.
[17]Nolan D, Watts GF, Herrmann SE, et al. Endothelial function in HIV_infecte d patients receiving protease inhibitor therapy:does immune competence affect ca rdiovascular risk[J]? QJM,2003,96:825-832.
[18]Mary_Krause M, Cotte L, Simon A, et al. Increased risk of myocardial infar ction with duration of protease inhibitor therapy in HIV_infected men.[J].AID S, 2003,17:2479-2486.
[19]Currier JS, Taylor A, Boyd F, et al. Coronary heart disease in HIV_infecte d individuals[J].J Acquir Immune Defic Syndr,2003,33:506-512., http://www.100md.com(范咏梅 王利宏)
[14]Egger M, Junghans C, Friis_Moller N, et al. Highly active antiretrovira l therapy and coronary heart disease:the need for perspective[J]. AIDS,2001,15 (suppl 5):S193-S201.
[15]Hsue PY, Lo JC, Franklin A, et al. Progression of atherosclerosis as asses sed by carotid intima_media thickness in patients with HIV infection[J]. Circ ulation,2004,109:1603-1608.
[16]Stein JH, Klein MA, Bellehumeur JL, et al.Use of human immunodeficiency vi rus_1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction[J].Circulation,2001,104:257-262.
[17]Nolan D, Watts GF, Herrmann SE, et al. Endothelial function in HIV_infecte d patients receiving protease inhibitor therapy:does immune competence affect ca rdiovascular risk[J]? QJM,2003,96:825-832.
[18]Mary_Krause M, Cotte L, Simon A, et al. Increased risk of myocardial infar ction with duration of protease inhibitor therapy in HIV_infected men.[J].AID S, 2003,17:2479-2486.
[19]Currier JS, Taylor A, Boyd F, et al. Coronary heart disease in HIV_infecte d individuals[J].J Acquir Immune Defic Syndr,2003,33:506-512., http://www.100md.com(范咏梅 王利宏)